Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?
A 60-year-old man with polyarteritis nodosa under treatment presented with syncope. Echocardiography demonstrated hypertrophic obstructive cardiomyopathy; coronary arteriography revealed normal findings, and Holter monitor showed episodes of non-sustained ventricular tachycardia. This is the first report of hypertrophic obstructive cardiomyopathy developing in a patient with polyarteritis nodosa. Further studies should examine whether a true association exists.
Papadopoulos
Dimitris P
DP
Department of Cardiology, Laiko Hospital of Athens, Athens, Greece. jimpapdoc@yahoo.com
Moyssakis
Ioannis
I
Votteas
Vassilios E
VE
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004452:Echocardiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D014700:Verapamil; D000638:Amiodarone; D008775:Methylprednisolone